Mike Patane

Biography

Michael A. Patane, Ph.D., also known as Mike, serves as Chief Science Officer and previously served as Senior Vice President of Drug Discovery at Mitobridge, Inc. Dr. Patane served as Consulting Chief Scientific Officer of Eyegate Pharmaceuticals, Inc. since January 2008 until August 5, 2016. He served as Vice President of Research & Development at Eyegate Pharmaceuticals, Inc. from July 25, 2007 to January 2008. Dr. Patane served as Corporate Advisor at Egenix, Inc. Dr. Patane has more than ten years of drug discovery experience with leading pharmaceutical and biotechnology organizations. Dr. Patane served as an Executive Director of Global Discovery Chemistry of the Novartis Institutes for BioMedical Research, where he was responsible for infectious diseases and ophthalmology drug discovery programs. Dr. Patane served as Director of Medicinal Chemistry of Millennium Pharmaceuticals, Inc., where he led drug discovery efforts for multiple oncology and metabolic disease research programs. Dr. Patane serves as a Scientific Advisorat Egenix, Inc. Dr. Patane served as a Research Fellow in Medicinal Chemistry at Merck & Co. He served as a Director of Eyegate Pharmaceuticals, Inc. Dr. Patane earned a B.S. in Chemistry from Fordham University, a PhD in Synthetic Organic Chemistry from the University of Southern California, and completed his post-doctoral studies in Synthetic, Natural Products, and Medicinal Chemistry at The Scripps Research Institute.

Research Interest

Informatics